They suggested that Gprc5a is a PTH (Parathyroid Hormone)-dependent gene that inhibits cell proliferation and osteoblast differentiation, and might be a suitable candidate as a drug target for osteoporosis. This evidence concerns the gene PTH and osteoporosis.